Beatriz I Fernandez-Gil

Dr. Beatriz I Fernandez-Gil

Mayo Clinic, Jacksonville, Alabama, USA
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2017 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
YSYing‐Qiang Shen
Ying‐Qiang Shen
AGAna Guerra-Librero
Ana Guerra-Librero
BFBeatriz I Fernandez-Gil
Beatriz I Fernandez-Gil
JRJavier Florido Ruiz
Javier Florido Ruiz
SGSergio García‐López
Sergio García‐López
Germaine EscamesGermaine Escames
Germaine Escames

12 April 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BFBeatriz I Fernandez-Gil
Beatriz I Fernandez-Gil
AMAhmed Abddel Moneim
Ahmed Abddel Moneim
FOFrancisco Ortiz
Francisco Ortiz
YSYing-Qiang Shen
Ying-Qiang Shen
VSViviana Soto-Mercado
Viviana Soto-Mercado
Germaine EscamesGermaine Escames
Germaine Escames
Radiotherapy-induced gut toxicity is among the most prevalent dose-limiting toxicities following radiotherapy. Prevention of radiation enteropathy requires protection of the small intestine. However, despite the prevalence and burden of this pathology, there are currently no effective treatments for radiotherapy-induced gut toxicity, and this pathology remains unclear. The present study aimed to investigate the changes induced in the rat small intestine after external irradiation of the tongue, and to explore the potential radio-protective effects of melatonin gel. Male Wistar rats were subjected to irradiation of their tongues with an X-Ray YXLON Y.Tu 320-D03 irradiator, receiving a dose of 7.5 Gy/day for 5 days. For 21 days post-irradiation, rats were treated with 45 mg/day melatonin gel or vehicle, by local application into their mouths. Our results showed that mitochondrial oxidative stress, bioenergetic impairment, and subsequent NLRP3 inflammasome activation were involved in the development of radiotherapy-induced gut toxicity. Oral treatment with melatonin gel had a protective effect in the small intestine, which was associated with mitochondrial protection and, consequently, with a reduced inflammatory response, blunting the NF-κB/NLRP3 inflammasome signaling activation. Thus, rats treated with melatonin gel showed reduced intestinal apoptosis, relieving mucosal dysfunction and facilitating intestinal mucosa recovery. Our findings suggest that oral treatment with melatonin gel may be a potential preventive therapy for radiotherapy-induced gut toxicity in cancer patients.

28 February 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
BFBeatriz I Fernandez-Gil
Beatriz I Fernandez-Gil
AGAna Guerra-Librero
Ana Guerra-Librero
YSYing-Qiang Shen
Ying-Qiang Shen
JRJavier Florido Ruiz
Javier Florido Ruiz
LMLaura Martínez-Ruiz
Laura Martínez-Ruiz
Germaine EscamesGermaine Escames
Germaine Escames
Head and neck cancer is the sixth leading cancer by incidence worldwide. Unfortunately, drug resistance and relapse are the principal limitations of clinical oncology for many patients, and the failure of conventional treatments is an extremely demoralizing experience. It is therefore crucial to find new therapeutic targets and drugs to enhance the cytotoxic effects of conventional treatments without potentiating or offsetting the adverse effects. Melatonin has oncostatic effects, although the mechanisms involved and doses required remain unclear. The purpose of this study is to determine the precise underlying mitochondrial mechanisms of melatonin, which increase the cytotoxicity of oncological treatments, and also to propose new melatonin treatments in order to alleviate and reverse radio- and chemoresistant processes. We analyzed the effects of melatonin on head and neck squamous cell carcinoma (HNSCC) cell lines (Cal-27 and SCC-9), which were treated with 0.1, 0.5, 1, and 1.5 mM melatonin combined with 8 Gy irradiation or 10 μM cisplatin. Clonogenic and MTT assays, as well as autophagy and apoptosis, involving flow cytometry and western blot, were performed in order to determine the cytotoxic effects of the treatments. Mitochondrial function was evaluated by measuring mitochondrial respiration, mtDNA content (RT-PCR), and mitochondrial mass (NAO). ROS production, antioxidant enzyme activity, and GSH/GSSG levels were analyzed using a fluorometric method. We show that high concentrations of melatonin potentiate the cytotoxic effects of radiotherapy and CDDP in HNSCC, which are associated with increased mitochondrial function in these cells. In HNSCC, melatonin induces intracellular ROS, whose accumulation plays an upstream role in mitochondria-mediated apoptosis and autophagy. Our findings indicate that melatonin, at high concentrations, combined with cisplatin and radiotherapy to improve its effectiveness, is a potential adjuvant agent.

31 March 2017 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
IRIbtissem Rahim
Ibtissem Rahim
BDBahia Djerdjouri
Bahia Djerdjouri
Ramy K. A. SayedRamy K. A. Sayed
Ramy K. A. Sayed
MOMarisol Fernández Ortiz
Marisol Fernández Ortiz
BFBeatriz I Fernandez-Gil
Beatriz I Fernandez-Gil
Dario Acuña-CastroviejoDario Acuña-Castroviejo
Dario Acuña-Castroviejo

19 April 2017 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
MMMiguel Mendivil-Perez
Miguel Mendivil-Perez
VSViviana Soto‐Mercado
Viviana Soto‐Mercado
AGAna Guerra-Librero
Ana Guerra-Librero
BFBeatriz I Fernandez-Gil
Beatriz I Fernandez-Gil
JRJavier Florido Ruiz
Javier Florido Ruiz
Germaine EscamesGermaine Escames
Germaine Escames

1 March 2016 in Mitochondrion
Verified
Journal Article
Closed access
CDCarolina Doerrier
Carolina Doerrier
JGJosé A. García
José A. García
HVHuayqui Volt
Huayqui Volt
MDM. Elena Díaz-Casado
M. Elena Díaz-Casado
MLMarta Luna-Sánchez
Marta Luna-Sánchez
Dario Acuña-CastroviejoDario Acuña-Castroviejo
Dario Acuña-Castroviejo